Literature DB >> 3280389

Transplantation for primary biliary cirrhosis.

C O Esquivel1, D H Van Thiel, A J Demetris, A Bernardos, S Iwatsuki, B Markus, R D Gordon, J W Marsh, L Makowka, A G Tzakis.   

Abstract

Primary biliary cirrhosis is a frequent indication for liver transplantation. The purpose of this report is to present our experience with liver transplantation for primary biliary cirrhosis. Attention is given to the causes of hepatic dysfunction seen in allografts. In addition, we review the postoperative problems encountered and the quality of life at time of last follow-up in patients with transplants for primary biliary cirrhosis. A total of 97 orthotopic liver transplant procedures were performed in 76 patients with advanced primary biliary cirrhosis at the University of Pittsburgh from March 1980 through September 1985. The transplant operation was relatively easy to perform. The most common technical complications experienced were fragmentation and intramural dissection of the recipient hepatic artery, which required an arterial graft in 20% of the cases. Most of the postoperative mortality occurred in the first 6 mo after transplantation, with an essentially flat actuarial life survival curve from that time point to a projected 5-yr survival of 66%. Common causes of death included rejection and primary graft nonfunction. Thirteen of the 76 patients had some hepatic dysfunction at the time of the last follow-up, although none were jaundiced. Recurrence of primary biliary cirrhosis could not be demonstrated in any of the patients. Antimitochondrial antibody was detected in the serum of almost all of the patients studied postoperatively for it. Most important, almost all of the 52 surviving patients have been rehabilitated socially and vocationally.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280389      PMCID: PMC3095835          DOI: 10.1016/0016-5085(88)90014-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS.

Authors:  E RUBIN; F SCHAFFNER; H POPPER
Journal:  Am J Pathol       Date:  1965-03       Impact factor: 4.307

2.  Alternative methods of arterialization of the hepatic graft.

Authors:  B W Shaw; S Iwatsuki; T E Starzl
Journal:  Surg Gynecol Obstet       Date:  1984-11

Review 3.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

Review 4.  Potential pathogenic mechanisms in primary biliary cirrhosis.

Authors:  H C Thomas
Journal:  Semin Liver Dis       Date:  1981-11       Impact factor: 6.115

Review 5.  The role of the immune response in the pathogenesis of primary biliary cirrhosis.

Authors:  S P James; J M Vierling; W Strober
Journal:  Semin Liver Dis       Date:  1981-11       Impact factor: 6.115

6.  Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients.

Authors:  E Christensen; J Crowe; D Doniach; H Popper; L Ranek; J Rodés; N Tygstrup; R Williams
Journal:  Gastroenterology       Date:  1980-02       Impact factor: 22.682

7.  Relationship of pretransplant hepatobiliary disease to bile duct damage occurring in the liver allograft.

Authors:  R H Fennell; R H Shikes; J M Vierling
Journal:  Hepatology       Date:  1983 Jan-Feb       Impact factor: 17.425

8.  The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis.

Authors:  J Roll; J L Boyer; D Barry; G Klatskin
Journal:  N Engl J Med       Date:  1983-01-06       Impact factor: 91.245

9.  Recurrence of primary biliary cirrhosis after liver transplantation.

Authors:  J Neuberger; B Portmann; B R Macdougall; R Y Calne; R Williams
Journal:  N Engl J Med       Date:  1982-01-07       Impact factor: 91.245

10.  Autoimmune associations in primary biliary cirrhosis.

Authors:  K S Culp; C R Fleming; J Duffy; W P Baldus; E R Dickson
Journal:  Mayo Clin Proc       Date:  1982-06       Impact factor: 7.616

View more
  14 in total

Review 1.  Liver transplantation. A primer for practicing gastroenterologists, Part I.

Authors:  V J Dindzans; R R Schade; J S Gavaler; R E Tarter; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

Review 2.  Liver transplantation for primary biliary cirrhosis.

Authors:  A G Tzakis; C Carcassonne; S Todo; L Makowka; T E Starzl
Journal:  Semin Liver Dis       Date:  1989-05       Impact factor: 6.115

Review 3.  Primary biliary cirrhosis.

Authors:  J Neuberger; M Lombard; R Galbraith
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 4.  Liver transplantation.

Authors:  J G O'Grady; B Portmann
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 5.  Liver transplantation--the first 25 years.

Authors:  H L Ascher
Journal:  West J Med       Date:  1988-09

Review 6.  Primary biliary cirrhosis: new perspectives.

Authors:  W C Maddrey
Journal:  Trans Am Clin Climatol Assoc       Date:  1989

Review 7.  Liver disease in women. Alcohol, autoimmunity, and gallstones.

Authors:  S Sherlock
Journal:  West J Med       Date:  1988-12

8.  Intrahepatic bile duct strictures after human orthotopic liver transplantation. Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection?

Authors:  J Lerut; A J Demetris; A C Stieber; J W Marsh; R D Gordon; C O Esquivel; S Iwatsuki; T E Starzl
Journal:  Transpl Int       Date:  1988-10       Impact factor: 3.782

Review 9.  Liver transplantation and primary biliary cirrhosis.

Authors:  A K Burroughs; M Biagini; P A McCormick; K Rolles
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

10.  Referral of patients with primary biliary cirrhosis for liver transplantation.

Authors:  J M Neuberger; B K Gunson; J A Buckels; E Elias; P McMaster
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.